Switching first-line targeted therapy after not reaching low disease activity within 6 months is superior to conservative approach: a propensity score-matched analysis from the ATTRA registry

BACKGROUND: Treat-to-target (T2T) is a widely accepted strategy for patients with rheumatoid arthritis (RA). It recommends attaining a goal of at least low disease activity (LDA) within 6 months; otherwise, the current therapy should be modified. We aimed to investigate whether switching a first-lin...

Descripción completa

Detalles Bibliográficos
Autores principales: Nekvindová, Lucie, Vencovský, Jiří, Pavelka, Karel, Horák, Pavel, Křístková, Zlatuše, Závada, Jakub
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789592/
https://www.ncbi.nlm.nih.gov/pubmed/33407803
http://dx.doi.org/10.1186/s13075-020-02393-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789592/
https://www.ncbi.nlm.nih.gov/pubmed/33407803
http://dx.doi.org/10.1186/s13075-020-02393-8

Ejemplares similares